These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
658 related items for PubMed ID: 19108788
1. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. Torkildsen G, O'Brien TP. Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG. Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346 [Abstract] [Full Text] [Related]
8. Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. Piñeyro-López A, Pineyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez Silva M, Wacksman N, Rangel RL, de Lago A, González-de la Parra M, Namur S. Clin Ther; 2005 Oct; 27(10):1607-11. PubMed ID: 16330296 [Abstract] [Full Text] [Related]
9. The effect of cataract surgery on ocular levels of topical moxifloxacin. Mather R, Stewart JM, Prabriputaloong T, Wong J, McLeod SD. Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780 [Abstract] [Full Text] [Related]
10. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. McCulley JP, Caudle D, Aronowicz JD, Shine WE. Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244 [Abstract] [Full Text] [Related]